55
Participants
Start Date
June 27, 2023
Primary Completion Date
April 5, 2024
Study Completion Date
April 21, 2025
Intravascular Lithotripsy
The Shockwave Medical IVL System is intended for lithotripsy-enhanced treatment of lesions, including calcified lesions, to increase luminal diameter, allowing for further treatment (e.g. post-dilatation) in the peripheral arterial vasculature. Not for use in the coronary or cerebral vasculature.
NYU Langone Health, New York
Lankenau Institute for Medical Research, Bryn Mawr
MedStar Montgomery Medical Center, Olney
Sentara Vascular Specialists, Norfolk
Charlotte Radiology, Charlotte
Tallahassee Memorial Healthcare, Inc., Tallahassee
HCA Florida Blake Hospital, Bradenton
Vanderbilt University Medical Center, Nashville
North Mississippi Medical Center, Tupelo
The Lindner Research Center at The Christ Hospital, Cincinnati
UnityPoint Health Trinity Bettendorf Hospital, Bettendorf
Cardiovascular Medicine PC, Davenport
Ascension Columbia St. Mary's, Milwaukee
Marshfield Medical Center, Marshfield
Ascension St. John Jane Phillips Hosptial, Bartlesville
The Heart Hospital Baylor, Plano
University of Texas Southwestern Medical Center, Dallas
Advanced Heart and Vein Center, Thornton
Stanford Hospital and Clinics (SHC), Palo Alto
Southcoast Hospitals Group, New Bedford
The Miriam Hospital, Providence
Shockwave Medical, Inc.
INDUSTRY